Cargando…
Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML
Autores principales: | Duployez, Nicolas, Martin, Jean-Edouard, Khalife-Hachem, Sabine, Benkhelil, Ryane, Saada, Véronique, Marzac, Christophe, Auger, Nathalie, Marceau-Renaut, Alice, Favier, Rémi, Ballerini, Paola, Caron, Olivier, Baruchel, André, de Botton, Stéphane, Preudhomme, Claude, Micol, Jean-Baptiste, Raslova, Hana, Antony-Debré, Iléana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746022/ https://www.ncbi.nlm.nih.gov/pubmed/31723833 http://dx.doi.org/10.1097/HS9.0000000000000203 |
Ejemplares similares
-
Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023) -
24. Radiographic evaluation of abutment for fpd
por: Shetty, Rajesh
Publicado: (2018) -
Hematopoietic Cell Autonomous Disruption of Hematopoiesis in a Germline Loss-of-function Mouse Model of RUNX1-FPD
por: Ernst, Martijn P. T., et al.
Publicado: (2023) -
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers
por: Khalife-Hachem, Sabine, et al.
Publicado: (2021) -
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
por: Lambert, Juliette, et al.
Publicado: (2021)